Search Results

Keywords: synthetic

Week in Review: Cannabis layoffs, regulators scrutinizing vitamin E acetate as vape villain, MI adult-use launch looms & more

Layoff announcements continue to weigh on the marijuana industry, state regulators focus on vitamin E acetate additive in vaporizer products as the vape crisis continues, Michigan businesses set their game plans for a December adult-use MJ launch, and more of the week’s top cannabis news. Pink slips pile up  Three well-known California cannabis companies this […]

Read More

Wellness products take off in the growing recreational cannabis market

Is the U.S. medical marijuana industry doomed? Amid news reports suggesting that MMJ markets are plateauing or shrinking in some states—particularly those that have approved the recreational use of marijuana, it’s reasonable to believe cannabis executives are bailing out of medical and plowing resources into adult-use products. Not so. Many cannabis companies are doubling down […]

Read More

The Battle Is Set: Human-Made versus Natural Cannabinoids

Of all the forces that will shape the future of medical marijuana, the rise of biosynthetic cannabinoids stands to be among the most disruptive—one that could pose a major competitive threat to medicine derived from the cannabis plant. But the extent and timing of that threat depends on a few factors. Several companies say they […]

Read More

Global Cannabis: Brazil

Milestones in the Medical Cannabis Program The National Sanitary Surveillance Agency regulated “compassionate use” imports in 2015.   Key Laws and Regulations RDC No. 17/2015 Portaria 344/1998   Market Data Since 2014, almost 10,000 authorizations were granted to individual patients, allowing them to import medical cannabis on a case-by-case basis, each for a period of […]

Read More

Growing Momentum: Brazil

Milestones in the Medical Cannabis Program The National Sanitary Surveillance Agency regulated “compassionate use” imports in 2015.   Key Laws and Regulations RDC No. 17/2015 Portaria 344/1998   Market Data Since 2014, almost 10,000 authorizations were granted to individual patients, allowing them to import medical cannabis on a case-by-case basis, each for a period of […]

Read More

Craft Cannabis: The Art of Cultivating

Nearly every marijuana cultivator wants to call its cannabis craft. Whether the plant is grown indoors or outside, with a hydroponic irrigation system or a watering can, under the sun or high-tech LED lights, few growers want their flower to be considered corporate cannabis. A marijuana company that appeals to the masses on a large […]

Read More

Bipartisan lawmakers offer congressional bill to promote cannabis, CBD research

A bipartisan group of U.S. senators introduced a federal bill to bolster marijuana and CBD research, a move that could encourage more doctors to recommend medical cannabis and expand legalization efforts. The bill also would amend the definition of marijuana in the federal Controlled Substances Act to exclude the synthetic equivalent of hemp-derived CBD that […]

Read More

Surterra partners with Intrexon in $100 million licensing cannabinoid deal

Surterra Wellness, an Atlanta-based cannabis company with operations in Florida and Texas, announced it will partner with Hungary’s Intrexon Corp. in a $100 million licensing deal aimed at biosynthetic cannabinoid production. Surterra would use Intrexon’s proprietary yeast fermentation platform to boost its cannabinoid production. Surterra is a privately held company; Intrexon trades on the Nasdaq […]

Read More

Breakthrough in Brazil: Regulators eye domestic cannabis cultivation, creation of product registration plan

Brazil could become the latest country to regulate the domestic cultivation of medical cannabis, according to the government body responsible for regulating marijuana – a move that will have major implications for the industry when the rules take effect. At a public meeting last week, the National Sanitary Surveillance Agency (ANVISA) collegiate directors approved two draft […]

Read More

Germany’s medical cannabis market prioritizes efficacy over unfettered access

Germany may be the largest and fastest-growing medical cannabis market in Europe, but signs are emerging from medical and regulatory circles that should serve as a warning to marijuana companies planning to commercialize medicines without conclusive clinical trials. In fact, businesses based on science and efficacy may see a competitive advantage in Germany in the […]

Read More